New Methods Of Treatment Of Ovarian Cancer

New Methods Of Treatment Of Ovarian Cancer.
Women with advanced ovarian cancer who draw spirited chemotherapy speedily into their stomach area may live at least one year longer than women who accept standard intravenous chemotherapy, a unique study says. But this survival edge may come at the detriment of more side effects. "The long-term benefits are lovely significant," said study author Dr Devansu Tewari, big cheese of gynecologic oncology at the Southern California Permanente Medical Group, in Orange County somali af hindi net. "There is no con of ovarian cancer treatments that has shown a greater survival advantage".

Intraperitoneal chemotherapy involves bathing the abdominal tract with chemotherapy agents. By contrast, intravenous (IV) chemotherapy is delivered throughout the body via the bloodstream provillus. The US National Cancer Institute currently recommends intraperitoneal remedy for women with ovarian cancer who have had top surgery to shed the tumor.

The 10-year reinforcement statistics from two studies of nearly 900 women with advanced ovarian cancer will be presented Saturday at the annual engagement of the Society of Gynecologic Oncology, in Los Angeles. In 2013, more than 22000 American women will be diagnosed with ovarian cancer, and more than 14000 will crave from the disease, according to the US National Cancer Institute. There are no anciently screening tests for ovarian cancer, which is why it is often diagnosed when the cancer has already develop the world at large of the ovaries.

For this reason, survival rates verge to be very low. In the supplemental study, women who received the intraperitoneal care were 17 percent more expected to survive longer than those who got IV chemotherapy. On average, women in the intraperitoneal sort survived for more than five years, while those who received IV chemotherapy survived for about four years, the swotting found. But survival benefits aside, intraperitoneal chemotherapy does talk a greater peril of side belongings - such as abdominal pain and numbness in the hands and feet - and not all women can weather this high concentration of cancer-killing drugs.

The drugs are also engrossed more slowly, providing more exposure to the medicine. The same properties that authorize the intraperitoneal therapy more effective likely with a role in causing more side effects, the researchers said. In general, six cycles of intraperitoneal chemotherapy are recommended, and can be given in inpatient or outpatient settings. The more cycles the women completed, the greater their survival advantage, the meditate on showed.